Status: current, Sufficiently defined by necessary conditions definition status. Date: 28-Feb 2022. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4696209011 | Dolutegravir and lamivudine and tenofovir only product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
4696210018 | Product containing only dolutegravir and lamivudine and tenofovir in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing only dolutegravir and lamivudine and tenofovir in oral dose form (medicinal product form) | Is a | Product containing only dolutegravir and lamivudine and tenofovir (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
Product containing only dolutegravir and lamivudine and tenofovir in oral dose form (medicinal product form) | Is a | Product containing dolutegravir and lamivudine and tenofovir in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing only dolutegravir and lamivudine and tenofovir in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing only dolutegravir and lamivudine and tenofovir in oral dose form (medicinal product form) | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing only dolutegravir and lamivudine and tenofovir in oral dose form (medicinal product form) | Has active ingredient | Lamivudine | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing only dolutegravir and lamivudine and tenofovir in oral dose form (medicinal product form) | Has active ingredient | Tenofovir | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing only dolutegravir and lamivudine and tenofovir in oral dose form (medicinal product form) | Has active ingredient | Dolutegravir | true | Inferred relationship | Existential restriction modifier | 3 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Product containing only dolutegravir and lamivudine and tenofovir in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets